valsartan has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZL; Da, YJ; Liang, LS; Nie, YY; Xin, T; Yan, YJ; Ye, Y; Yuan, WD | 1 |
| Kamimura, R; Kawana, S; Nishisako, R; Urabe, T | 1 |
2 other study(ies) available for valsartan and Prostatic Neoplasms
| Article | Year |
|---|---|
Synthesis and biological evaluation of new fluorine substituted derivatives as angiotensin II receptor antagonists with anti-hypertension and anti-tumor effects.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Hydrocarbons, Fluorinated; Hypertension; Male; Mice; Mice, Nude; Prostatic Neoplasms; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2012 |
[Case of drug-induced angioedema (DIAE) on induction of anesthesia with difficult ventilation due to oropharyngeal edema].
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Angioedema; Angiotensin Receptor Antagonists; Edema; Humans; Intubation, Intratracheal; Male; Pharyngeal Diseases; Prostatectomy; Prostatic Neoplasms; Severity of Illness Index; Tetrazoles; Valine; Valsartan | 2014 |